ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/06 | 1,347 | 1,351 | 1,281 | 1,302 | -37 | -2.8% | 1,555,800 |
| 2024/09/05 | 1,320 | 1,353 | 1,316 | 1,339 | +9 | +0.7% | 1,167,900 |
| 2024/09/04 | 1,369 | 1,378 | 1,328 | 1,330 | -76 | -5.4% | 1,922,800 |
| 2024/09/03 | 1,415 | 1,445 | 1,386 | 1,406 | -4 | -0.3% | 1,647,600 |
| 2024/09/02 | 1,458 | 1,472 | 1,407 | 1,410 | +10 | +0.7% | 2,791,800 |
| 2024/08/30 | 1,471 | 1,500 | 1,376 | 1,400 | -59 | -4% | 4,751,100 |
| 2024/08/29 | 1,480 | 1,482 | 1,394 | 1,459 | -258 | -15% | 6,130,500 |
| 2024/08/28 | 1,688 | 1,717 | 1,672 | 1,717 | +33 | +2% | 352,900 |
| 2024/08/27 | 1,720 | 1,747 | 1,676 | 1,684 | -30 | -1.8% | 808,000 |
| 2024/08/26 | 1,730 | 1,730 | 1,707 | 1,714 | -17 | -1% | 410,300 |
| 2024/08/23 | 1,725 | 1,732 | 1,699 | 1,731 | +5 | +0.3% | 608,000 |
| 2024/08/22 | 1,670 | 1,733 | 1,665 | 1,726 | +66 | +4% | 755,900 |
| 2024/08/21 | 1,693 | 1,695 | 1,644 | 1,660 | -42 | -2.5% | 582,900 |
| 2024/08/20 | 1,671 | 1,703 | 1,652 | 1,702 | +37 | +2.2% | 949,400 |
| 2024/08/19 | 1,644 | 1,677 | 1,629 | 1,665 | +17 | +1% | 633,000 |
| 2024/08/16 | 1,580 | 1,654 | 1,577 | 1,648 | +92 | +5.9% | 1,104,500 |
| 2024/08/15 | 1,565 | 1,571 | 1,545 | 1,556 | +6 | +0.4% | 506,400 |
| 2024/08/14 | 1,585 | 1,586 | 1,534 | 1,550 | -12 | -0.8% | 862,300 |
| 2024/08/13 | 1,502 | 1,582 | 1,495 | 1,562 | +71 | +4.8% | 984,900 |
| 2024/08/09 | 1,518 | 1,523 | 1,473 | 1,491 | +3 | +0.2% | 704,100 |
| 2024/08/08 | 1,474 | 1,507 | 1,466 | 1,488 | +10 | +0.7% | 586,800 |
| 2024/08/07 | 1,425 | 1,507 | 1,404 | 1,478 | +24 | +1.7% | 1,071,600 |
| 2024/08/06 | 1,421 | 1,474 | 1,413 | 1,454 | +75 | +5.4% | 2,163,600 |
| 2024/08/05 | 1,479 | 1,528 | 1,343 | 1,379 | -180 | -11.5% | 2,189,700 |
| 2024/08/02 | 1,643 | 1,660 | 1,550 | 1,559 | -104 | -6.3% | 1,534,000 |
| 2024/08/01 | 1,682 | 1,690 | 1,647 | 1,663 | -17 | -1% | 605,900 |
| 2024/07/31 | 1,696 | 1,701 | 1,642 | 1,680 | -22 | -1.3% | 617,000 |
| 2024/07/30 | 1,691 | 1,709 | 1,678 | 1,702 | +9 | +0.5% | 913,700 |
| 2024/07/29 | 1,695 | 1,702 | 1,683 | 1,693 | +3 | +0.2% | 499,100 |
| 2024/07/26 | 1,687 | 1,703 | 1,668 | 1,690 | +3 | +0.2% | 629,200 |
| 2024/07/25 | 1,703 | 1,726 | 1,683 | 1,687 | -17 | -1% | 1,519,600 |
| 2024/07/24 | 1,645 | 1,754 | 1,645 | 1,704 | +59 | +3.6% | 1,733,600 |
| 2024/07/23 | 1,630 | 1,656 | 1,625 | 1,645 | +8 | +0.5% | 387,800 |
| 2024/07/22 | 1,627 | 1,641 | 1,606 | 1,637 | +17 | +1% | 440,100 |
| 2024/07/19 | 1,640 | 1,649 | 1,620 | 1,620 | -14 | -0.9% | 399,900 |
| 2024/07/18 | 1,660 | 1,696 | 1,619 | 1,634 | -36 | -2.2% | 945,800 |
| 2024/07/17 | 1,665 | 1,684 | 1,663 | 1,670 | +21 | +1.3% | 458,300 |
| 2024/07/16 | 1,669 | 1,684 | 1,646 | 1,649 | -31 | -1.8% | 709,700 |
| 2024/07/12 | 1,638 | 1,690 | 1,634 | 1,680 | +25 | +1.5% | 915,500 |
| 2024/07/11 | 1,677 | 1,677 | 1,633 | 1,655 | -12 | -0.7% | 749,000 |
| 2024/07/10 | 1,692 | 1,700 | 1,653 | 1,667 | -13 | -0.8% | 739,300 |
| 2024/07/09 | 1,633 | 1,681 | 1,632 | 1,680 | +61 | +3.8% | 976,900 |
| 2024/07/08 | 1,622 | 1,638 | 1,613 | 1,619 | +11 | +0.7% | 330,600 |
| 2024/07/05 | 1,625 | 1,638 | 1,605 | 1,608 | +3 | +0.2% | 351,400 |
| 2024/07/04 | 1,642 | 1,646 | 1,605 | 1,605 | -36 | -2.2% | 412,900 |
| 2024/07/03 | 1,590 | 1,641 | 1,590 | 1,641 | +62 | +3.9% | 681,800 |
| 2024/07/02 | 1,565 | 1,586 | 1,562 | 1,579 | +11 | +0.7% | 487,200 |
| 2024/07/01 | 1,607 | 1,609 | 1,561 | 1,568 | -35 | -2.2% | 590,300 |
| 2024/06/28 | 1,609 | 1,615 | 1,600 | 1,603 | -9 | -0.6% | 464,600 |
| 2024/06/27 | 1,621 | 1,671 | 1,609 | 1,612 | +7 | +0.4% | 1,240,400 |
51～
100
件表示中 / 4975件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 113,700円 | +197.7% | - | 0.00% | 46.47倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 332,000円 | +3.0% | +27.5% | 2.41% | 21.02倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 222,100円 | +13.6% | +29.2% | 2.07% | 11.52倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 149,100円 | +3.2% | +4.5% | 3.49% | 17.13倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 69,600円 | -3.7% | -36.7% | 2.87% | 22.92倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
